Assignee
ACEVEDO-DUNCAN MILDRED
US·2 granted patents·4 pending applications·1 citations·filing 2008–2019
Top patents by PatentIndex Score
6 records- 0153US8461192B2Method of selectively inhibiting PKCiotaACEVEDO-DUNCAN MILDRED·Filed 2008·Granted Jun 11, 2013·1 cites·6 claims
- 0253US2009130195A1Prostate carcinogenesis predictorACEVEDO-DUNCAN MILDRED·Filed 2008·Application pending·0 cites
- 0343US2012171219A1Use of pkc-zeta as a breast cancer tumorigenic biomarker as well as a target for treatment of breast cancerACEVEDO-DUNCAN MILDRED·Filed 2011·Application pending·0 cites
- 0441US8603758B2Prostate carcinogenesis predictorACEVEDO-DUNCAN MILDRED·Filed 2012·Granted Dec 10, 2013·0 cites·12 claims
- 0539US2017304223A1Method of treating prostate cancer using a pkc inhibitorACEVEDO-DUNCAN MILDRED·Filed 2017·Application pending·0 cites
- 0638US2020078323A1Method of treating ovarian cancer using zeta-statACEVEDO DUNCAN MILDRED·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ACEVEDO-DUNCAN MILDRED files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →